|
As part of heartflow's quality monitoring process, we identified a potential false negative.(b)(4).The investigation identified a potential false negative in the lcx region; after the initial analysis was delivered, a second analysis completed as part of ongoing quality review resulted in a decrease in the ffrct value from 0.75 to <0.50 on the distal lcx.While heartflow has identified this issue, the physician has not provided feedback, nor indicated a safety event with the patient.
|